Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
Vorinostat in combination with lenalidomide and dexamethasone in patients with relapsed or refractory multiple myeloma
David S. Siegel, Paul G. Richardson, Meletios A Dimopoulos, Philippe Moreau, C Mitsiades, D. Weber, Jennifer Houp, Christine K. Gause, Scott Vuocolo, Joe Eid, Thorsten Graef, Kenneth C. Anderson (2014). Vorinostat in combination with lenalidomide and dexamethasone in patients with relapsed or refractory multiple myeloma. , 4 (2), DOI: https://doi.org/10.1038/bcj.2014.1.
Corrigendum37 days agoLenalidomide and dexamethasone (LEN plus DEX) treatment in relapsed/refractory multiple myeloma (RRMM) patients (pts) and risk of second primary malignancies (SPM): Analysis of MM-009/010.
Meletios A Dimopoulos, Robert Z. Orlowski, Rubén Niesvizky, Sagar Lonial, Nancy A. Brandenburg, D. Weber (2011). Lenalidomide and dexamethasone (LEN plus DEX) treatment in relapsed/refractory multiple myeloma (RRMM) patients (pts) and risk of second primary malignancies (SPM): Analysis of MM-009/010.. , 29(15_suppl), DOI: https://doi.org/10.1200/jco.2011.29.15_suppl.8009.
Article37 days agoPhase I study of combined vorinostat (V), lenalidomide (L), and dexamethasone (D) in patients (pts) with relapsed or refractory multiple myeloma (MM).
Paul G. Richardson, D. Weber, Constantine S. Mitsiades, Meletios A Dimopoulos, Jean‐Luc Harousseau, J. Howe, Thorsten Graef, Clare Byrne, Kenneth C. Anderson, David S. Siegel (2010). Phase I study of combined vorinostat (V), lenalidomide (L), and dexamethasone (D) in patients (pts) with relapsed or refractory multiple myeloma (MM).. , 28(15_suppl), DOI: https://doi.org/10.1200/jco.2010.28.15_suppl.8031.
Article37 days agoThe efficacy and safety of lenalidomide plus dexamethasone in relapsed or refractory multiple myeloma patients with impaired renal function
D. Weber, Andrew Spencer, M. Wang, C. Chen, Michel Attal, Rubén Niesvizky, Martin Prince, Zhinuan Yu, Robert Knight, Meletios A Dimopoulos (2008). The efficacy and safety of lenalidomide plus dexamethasone in relapsed or refractory multiple myeloma patients with impaired renal function. , 26(15_suppl), DOI: https://doi.org/10.1200/jco.2008.26.15_suppl.8542.
Article37 days agoAsymptomatic Waldenstrom's macroglobulinemia
Raymond Alexanian, D. Weber, Kay Delasalle, Fernando Cabanillas, Meletios A Dimopoulos (2003). Asymptomatic Waldenstrom's macroglobulinemia. , 30(2), DOI: https://doi.org/10.1053/sonc.2003.50051.
Article37 days ago